QIAGEN OmicSoft and Biomedical Knowledge Base

Using OmicSoft OncoLand to integrate public expression

58 views
March 12, 2025

QIAGEN OmicSoft Lands are high-quality curated repositories of genomics and proteomics data sourced from public, published studies (GEO, EBI, SRA) and consortia (TCGA, CPTAC, GTEx, and more). Because of our expert curation and stringent quality checks, OmicSoft users can deeply investigate across diverse oncology and normal tissue/cell datasets to discover and validate candidate drug targets and biomarkers.

 

In this training, attendees will use OmicSoft Studio, our graphical user interface, to access public data from The Cancer Genome Atlas (TCGA). Using this data, you will learn how to:

• View gene expression and somatic mutation frequency across different tumor types and conditions

• Identify genes whose expression correlates or anti-correlates with mutation of your target

• Prioritize your candidate biomarkers using expression data across comparisons (tumor vs. normal, MUT vs. WT, etc.)

• Establish survival consequences from changes in your candidate biomarker’s expression or mutation status

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

1,984 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

Supercharge your AI in drug discovery with high-quality biomedical data

650 views October 11, 2023

If you’re working in pharma or biotech, you likely rely on artificial...

QIAGEN OmicSoft and Biomedical Knowledge Base

Unlocking the power of API-based 'omics queries

591 views June 12, 2023

If you're a data scientist or bioinformatician working in biopharma, here's...

QIAGEN OmicSoft and Biomedical Knowledge Base

Integrating deeply curated omics data with APIs for biomarkers and drug-target investigation

479 views September 19, 2023

If you’re a data scientist or bioinformatician working in biopharma and need...